Viewing Study NCT00101595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-02-20 @ 6:34 PM
Study NCT ID: NCT00101595
Status: COMPLETED
Last Update Posted: 2011-04-14
First Post: 2005-01-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia View
None Leukemia, Lymphoblastic, Acute, Philadelphia-positive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoid blast phase chronic myeloid leukemia View
None Philadelphia chromosome positive acute lymphoblastic leukemia View